Company Filing History:
Years Active: 2002-2013
Title: Innovations by Inventor Stephan Rimpler
Introduction
Stephan Rimpler is a notable inventor based in Hilden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for drug administration. With a total of four patents to his name, Rimpler has focused on enhancing the efficacy and delivery of pharmacologically active ingredients.
Latest Patents
Rimpler's latest patents include a method for producing a pharmaceutical composition comprising rotigotine. This invention provides pharmaceutical compositions for the administration of rotigotine in depot form, ensuring therapeutically significant plasma levels over a period of at least 24 hours after administration. Another significant patent is for an injectable pharmaceutical composition for the systemic administration of pharmacologically active ingredients. This composition includes a solid-phase active ingredient, a vehicle of polyol fatty acid esters, and a wetting agent, allowing for the release of ingredients over at least 12 to 24 hours.
Career Highlights
Throughout his career, Rimpler has worked with prominent companies in the pharmaceutical industry, including Schwarz Pharma AG and UCB Pharma GmbH. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Rimpler has collaborated with notable professionals in the field, including Christoph Arth and Andreas Kollmeyer-Seeger. These collaborations have likely enriched his work and contributed to the advancements in pharmaceutical compositions.
Conclusion
Stephan Rimpler is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact drug delivery and efficacy. His innovative patents reflect a commitment to improving patient care through advanced pharmaceutical technologies.